Correlation Between Inozyme Pharma and Palatin Technologies
Can any of the company-specific risk be diversified away by investing in both Inozyme Pharma and Palatin Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inozyme Pharma and Palatin Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inozyme Pharma and Palatin Technologies, you can compare the effects of market volatilities on Inozyme Pharma and Palatin Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inozyme Pharma with a short position of Palatin Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inozyme Pharma and Palatin Technologies.
Diversification Opportunities for Inozyme Pharma and Palatin Technologies
-0.06 | Correlation Coefficient |
Good diversification
The 3 months correlation between Inozyme and Palatin is -0.06. Overlapping area represents the amount of risk that can be diversified away by holding Inozyme Pharma and Palatin Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Palatin Technologies and Inozyme Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inozyme Pharma are associated (or correlated) with Palatin Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Palatin Technologies has no effect on the direction of Inozyme Pharma i.e., Inozyme Pharma and Palatin Technologies go up and down completely randomly.
Pair Corralation between Inozyme Pharma and Palatin Technologies
Given the investment horizon of 90 days Inozyme Pharma is expected to generate 0.75 times more return on investment than Palatin Technologies. However, Inozyme Pharma is 1.33 times less risky than Palatin Technologies. It trades about 0.05 of its potential returns per unit of risk. Palatin Technologies is currently generating about 0.0 per unit of risk. If you would invest 177.00 in Inozyme Pharma on October 7, 2024 and sell it today you would earn a total of 130.00 from holding Inozyme Pharma or generate 73.45% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Inozyme Pharma vs. Palatin Technologies
Performance |
| Timeline |
| Inozyme Pharma |
| Palatin Technologies |
Inozyme Pharma and Palatin Technologies Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Inozyme Pharma and Palatin Technologies
The main advantage of trading using opposite Inozyme Pharma and Palatin Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inozyme Pharma position performs unexpectedly, Palatin Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Palatin Technologies will offset losses from the drop in Palatin Technologies' long position.| Inozyme Pharma vs. Day One Biopharmaceuticals | Inozyme Pharma vs. X4 Pharmaceuticals | Inozyme Pharma vs. Acumen Pharmaceuticals | Inozyme Pharma vs. Mereo BioPharma Group |
| Palatin Technologies vs. Fortress Biotech | Palatin Technologies vs. Checkpoint Therapeutics | Palatin Technologies vs. Avenue Therapeutics | Palatin Technologies vs. Aileron Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Complementary Tools
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |